HCV
OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate
The firm attributed its quarterly and annual revenue gains primarily to sales of COVID-19 testing sample collection devices.
OraSure Technologies Q2 Revenues Drop 25 Percent, Miss Analysts Estimates
The firm said declines across most business areas were slightly offset by increases in sales of sample collection devices.
FDA Proposes Reclassification of HCV RNA, Antibody Tests
If the proposal is finalized, the tests will go through a less burdensome process to obtain marketing clearances.
USPSTF Updates HCV Screening Recommendations to Include All Adults
An increase in in the incidence of acute HCV infection in younger people, particularly those who inject drugs, contributed to the updated guidance.
OraSure Technologies Q4 Revenues Down 1 Percent
The firm saw strong increases in international HIV sales of its OraQuick HIV Self-Test product in the quarter.
Oct 15, 2019
Enzo Biochem Fiscal Q4 Revenues Down 8 Percent
Aug 6, 2019
OraSure Technologies Q2 Revenues Down 11 Percent
Jun 25, 2019
NeuMoDx Gets CE Mark on Hepatitis B and C Assays
May 8, 2019
OraSure Technologies Q1 Revenues Down 28 Percent
Apr 25, 2019
Feb 6, 2019
OraSure Technologies Q4 Revenues Down 3 Percent
Dec 18, 2018
Systaaq HBV Assay Receives CE Mark
Nov 7, 2018
OraSure Q3 Revenues Up 8 Percent
Jul 5, 2018